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S U MM A R Y
BACKGROUND : Tuberculosis (TB) is a major concern
among high-risk populations such as the homeless.
OB J E C T I V E S : To evaluate TB incidence and treatment
outcomes among homeless patients in Portugal and to
identify predictors of unsuccessful TB treatment out-
comes among the homeless.
DE S I GN : This was a retrospective cohort study of all
TB patients notified in Portugal from 2008 to 2014.
Characteristics of homeless TB patients were assessed
and predictors of unsuccessful TB treatment were
determined using logistic regression.
R E SU LT S : TB incidence among the homeless was 122/
100 000 homeless persons and was positively correlated
with TB incidence among non-homeless persons.
Homeless TB patients had a higher prevalence of alcohol
and/or drug use, human immunodeficiency virus (HIV)
co-infection, cavitary TB and smear positivity. The rate
of unsuccessful treatment outcomes among the homeless
was 28.6%, and was significantly associated with
increased age, injection drug use (IDU) and HIV co-
infection.
CONC LU S I ON : TB incidence among homeless persons
was five times that among the non-homeless, and higher
in regions with greater TB incidence among non-
homeless persons. The successful treatment outcome
rate was lower. Predictors of unsuccessful treatment
were age, IDU and HIV co-infection. Integrated TB
programmes targeting homeless and non-homeless
patients, with measures targeting specific characteristics,
may contribute to TB elimination in Portugal.
K E Y WORD S : homelessness; predictors; treatment suc-
cess
TUBERCULOSIS (TB) remains one of the leading
causes of death due to an infectious agent world-
wide.1 Although TB incidence has decreased in
industrialised countries, it remains a major cause of
disease among high-risk populations such as the
homeless.2,3 The definition of homelessness varies
from country to country. In 2009, at the United
Nations Economic Commission for Europe Confer-
ence of European Statisticians, a homeless person was
defined as a person living in the streets without a
shelter or a person with no place of usual residence,
who moves frequently between various types of
accommodation.4
Although the association between TB and home-
lessness was recognised at the beginning of the
twentieth century,5 there are few worldwide studies
on the subject. Data evaluating TB incidence and the
socio-economic factors associated with TB in this
group are hard to obtain, as reports on the total
number of homeless persons and their characteristics
are scarce. Some studies have reported a lower
treatment success rate among homeless TB patients;
however, the predictive factors for unsuccessful
treatment outcomes have not been well studied.2,3,6,7
The aims of the present study were to evaluate the
TB incidence rate and assess treatment outcomes
among the homeless in Portugal, and to identify
predictors for unsuccessful treatment.
STUDY POPULATION AND METHODS
Study design and data collection
This was a retrospective cohort study conducted in
Portugal. The data source was the latest Census
(2011) provided by the National Statistical System
(INE)8 and the National TB Surveillance System
Correspondence to: Margarida Dias, Pulmonology Department, Centro Hospitalar Vila Nova de Gaia/Espinho, Rua
Conceic¸a˜o Fernandes, S/N, 4434-502 Vila Nova de Gaia, Portugal. e-mail: margarida.pinho.dias@chvng.min-saude.pt
Article submitted 5 August 2016. Final version accepted 7 November 2016.
(SVIG). In Portugal, the notification of all reported
TB cases to the SVIG is mandatory; a standard form
covering, among other items, the patient’s demo-
graphic data, geographic localisation, housing status,
human immunodeficiency virus (HIV) status, sub-
stance use, drug susceptibility testing results and
treatment outcome is used.
We calculated the national TB incidence among
homeless and non-homeless persons for 2011. The
association between TB incidence among homeless
persons and national indicators by territorial unit was
analysed using an ecological study design. Portugal is
divided into 18 districts and two autonomous
regions, and this was the territorial unit selected.
The national indicators obtained from the 2011
Census were population density, number of homeless
persons, prevalence of migrants, number of physi-
cians per inhabitant and unemployment rate. We
selected all TB cases reported to the SVIG during
2008–2014 for the study analysis. We first compared
treatment outcomes by housing status (homeless vs.
non-homeless), and then identified predictors of
unsuccessful treatment in the homeless subgroup.
Ethical approval for the study was not required, as
only encrypted information was used.
Definitions
A person was considered homeless if he/she did not
have a regular and adequate residence or lived in a
temporary residence provided by a social institution.
TB treatment outcomes were described as successful
or unsuccessful. Successful treatment outcomes in-
cluded treatment completion and cure; unsuccessful
treatment outcomes included treatment failure, loss
to follow-up, transferred out or died, based on World
Health Organization definitions.1
Statistical analysis
For district-wise data, the strength of the (monotone)
association between the national indicators selected
and TB incidence among homeless persons was
evaluated using the Spearman’s rank correlation
coefficient. Descriptive statistics of the variables of
interest were expressed as absolute and relative
frequencies or means 6 standard deviation. v2 and
t-tests were used to evaluate the statistical signifi-
cance of the independence between each risk factor
and the response. Logistic regression models were
used to identify risk factors for unsuccessful TB
treatment outcomes among homeless patients.
The choice of the best model was based on the
(lowest) Akaike Information Criterion. The proba-
bility threshold leading to the maximum value of the
sum between sensitivity and specificity was comput-
ed, which should define the cut-off for class
membership if predictions are to be made. All
statistical analyses were performed using R software
environment for statistical computation and graphics,
version 3.3.0 (R Computing, Vienna, Austria).9 The
significance level was set at 0.05.
RESULTS
2011 TB incidence rate among homeless persons
The 2011 Census identified 92 053 homeless persons
among a total population of 10 562 178 in Portugal.
In the same year, 2609 TB cases were notified, 112
(4%) of whom were homeless. The TB incidence rate
among homeless persons was therefore 122 per
100 000 homeless persons, while among non-home-
less persons this was 23/100 000 population.
Table 1 shows the results of the association
between TB incidence among homeless persons and
the national indicators evaluated. As mentioned
earlier, calculations were based on dividing Portugal
into 20 territorial units. Of the indicators evaluated,
TB incidence among the non-homeless had the
strongest positive correlation with TB incidence
among the homeless (Table 1).
TB outcomes, 2008–2014
Between 2008 and 2014, 18 380 cases of TB disease
were reported to the SVIG. We excluded 725 patients
due to unknown housing status. Of the 17 655
patients included, 734 (4%) were homeless. Table 2
shows the univariate analyses of patient characteris-
tics by housing status. Most homeless TB patients
were male (77.7%) and were aged between 25 and 64
years (76.8%). The prevalence of alcohol abuse was
three times higher (33.3% vs. 12.8%) and drug use
almost five times higher (41.3% vs. 8.4%) among
homeless persons than among the non-homeless.
There was also a higher prevalence of immigrants
(21.1% vs. 15.3%), previous TB diagnosis (12.7% vs.
8.8%) and HIV co-infection (32.6% vs. 10.1%)
among the homeless. With regard to the clinical
characteristics analysed, the prevalence of positive
acid-fast bacilli (AFB) in respiratory specimens and
cavitary lung disease was significantly higher in
homeless patients (70.7% vs. 65.8% and 44.6% vs.
39.0%, respectively). Extra-pulmonary disease was
more frequent in non-homeless patients (32.3% vs.
27.2%). There were no differences between homeless
and non-homeless persons regarding susceptibility of
Table 1 Spearman’s correlation between national indicators
and TB incidence among homeless persons, Portugal, 2011
National indicators
Correlation
coefficient P value
TB incidence in the general population 0.795 ,0.001
Number of homeless persons 0.539 0.014
Population density 0.379 0.100
Number of physicians/inhabitants 0.328 0.157
Prevalence of immigrants 0.303 0.195
Unemployment rate 0.092 0.716
TB¼ tuberculosis.
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Mycobacterium tuberculosis to isoniazid (INH) and/
or rifampicin (RMP).
Overall, the prevalence of unsuccessful treatment
outcomes was higher in homeless patients than in
non-homeless patients (28.6% vs. 9.9%). The rate of
treatment failure was similar (0% vs. ,0.1%);
however, homeless persons had a higher mortality
rate (14.4% vs. 5.4%), a higher number of cases lost
to follow-up (9.4% vs. 3%) and a higher number of
patients transferred out (4.7% vs. 1.5%).
Predictors of unsuccessful TB treatment outcomes in
homeless persons, 2008–2014
Of the 734 homeless patients, TB treatment outcomes
were reported for 653. The univariate analysis of
characteristics associated with unsuccessful treatment
is shown in Table 3. The final model identified age,
injection drug use (IDU) and HIV co-infection to be
positively associated with unsuccessful treatment in
this group (Table 4). For each 1-year increase in age,
the odds of unsuccessful treatment increased by 3%.
For example, a 10-year increase in age would lead to
30% higher odds of unsuccessful treatment. Individ-
uals with HIV co-infection had 2.1 times higher odds
of having unsuccessful treatment than non-HIV-
infected patients. The odds of unsuccessful treatment
among injection drug users were twice as high as
those of non-users. No significant interactions
between these variables were identified. The area
under the receiver operating characteristic curve
(AUC) for this model to estimate an unsuccessful
treatment outcome was 0.676 (95% confidence
Table 2 Characteristics of homeless and non-homeless persons with TB disease
Homeless persons
(n ¼ 734)
n (%)
Non-homeless persons
(n ¼ 16 921)
n (%) P value
Male sex 570 (77.7) 10 941 (64.7) ,0.001
Age, years, mean 6 SD 48.1 6 18.4 46.8 6 18.9 0.045
Substance use
Alcohol use 222 (33.3) 1 987 (12.0) ,0.001
Drug use 280 (41.3) 1 391 (8.4) ,0.001
Immigrant 155 (21.1) 2 591 (15.3) ,0.001
Previous TB 93 (12.7) 1 484 (8.8) ,0.001
Clinical characteristics
AFB smear-positive respiratory specimens 395 (70.7) 7 550 (65.8) 0.018
Cavitary lung disease 300 (44.6) 6 154 (39.0) 0.003
Extra-pulmonary disease 198 (27.2) 5 261 (32.3) 0.003
HIV-positive result 239 (32.6) 1 717 (10.1) ,0.001
Isoniazid resistance 30 (6.8) 684 (7.2) 0.260
Rifampicin resistance 13 (2.9) 175 (1.8) 0.171
MDR-TB 11 (2.5) 159 (1.7) 0.201
TB treatment outcome ,0.001
Successful 443 (60.4) 13 743 (81.3)
Unsuccessful 210 (28.6) 1 681 (9.9)
Not reported 81 (11.0) 1 497 (8.8)
TB¼ tuberculosis; SD¼ standard deviation; AFB¼ acid-fast bacilli; HIV¼ human immunodeficiency virus; MDR-TB¼multidrug-resistant TB.
Table 3 Characteristics of homeless TB patients by treatment outcome
Unsuccessful treatment
(n ¼ 210)
n (%)
Successful treatment
(n ¼ 443)
n (%) P value
Male sex 161 (76.7) 343 (77.4) 0.829
Age, years, mean 6 SD 52.5 6 19.7 46.2 6 17.7 ,0.001
Substance use
Alcohol abuse 59 (33.1) 133 (32.3) 0.837
Non-injection drug use 67 (36.2) 129 (31.5) 0.254
Injection drug use 85 (44.7) 124 (30.1) ,0.001
Immigrant 42 (20.0) 96 (21.7) 0.625
Previous TB 32 (15.2) 51 (11.5) 0.182
Clinical characteristics
AFB smear-positive respiratory specimens 111 (71.2) 237 (68.9) 0.611
Cavitary lung disease 80 (43.5) 181 (43.7) 0.956
Extra-pulmonary disease 55 (26.2) 123 (28.1) 0.614
HIV co-infection 87 (41.4) 126 (28.4) 0.001
Isoniazid resistance 10 (7.9) 16 (5.4) 0.318
Rifampicin resistance 5 (4) 5 (1.7) 0.157
MDR-TB 4 (3.2) 4 (1.3) 0.207
TB¼ tuberculosis; SD¼ standard deviation; AFB¼ acid-fast bacilli; HIV¼ human immunodeficiency virus; MDR-TB¼multidrug-resistant TB.
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interval 0.631–0.721). The probability threshold
maximising the sum of sensitivity with specificity
was estimated at 0.617, leading to individual
sensitivity and specificity values of respectively
0.706 and 0.577.
DISCUSSION
TB incidence among homeless persons was approx-
imately five times higher than among the non-
homeless. In Portugal, TB incidence in 2003 among
the homeless (122/100 000 homeless) was higher than
the incidence reported in the United States (36–47/
100 000 homeless), but lower than that in London,
UK (788/100 000 homeless).2,3
Those regions in Portugal with higher TB incidence
among the homeless also recorded higher TB inci-
dence in the non-homeless population. Furthermore,
the majority of TB patients were non-homeless
persons (96%). We therefore hypothesise that better
TB control in the non-homeless population would
reduce TB among homeless persons. We do, however,
recognise that as this hypothesis is based on an
ecological study design, our findings for the groups
may not apply to individuals in each group. Our study
identified distinct clinical characteristics of homeless
TB patients, which requires an approach specific to
this population that could contribute to the develop-
ment of a more comprehensive TB control pro-
gramme.
The prevalence of alcohol and/or drug use, condi-
tions associated with a higher risk of TB disease and
poor treatment adherence, was higher among home-
less TB patients.10 It is therefore important to take
measures to treat drug addiction in homeless TB
patients. Almost one third of homeless TB patients
presented with HIV co-infection. HIV infection is a
major risk factor for latent tuberculous infection
(LTBI) and TB disease, and the presence of TB-HIV
co-infection is often associated with drug interactions,
overlapping toxicity profiles and higher mortality.11
The large number of homeless persons with TB-HIV
co-infection highlights the need for a structured
screening programme for LTBI and active TB in
homeless patients, particularly in the case of HIV-
positive patients. According to a computer simulation
model created by Brewer et al., a 10% increase in
accessing treatment for LTBI by HIV-infected homeless
persons was associated with an 8.9–10.9% decline in
projected TB cases over 10 years.12
Furthermore, 71.2% of homeless persons were
AFB smear-positive and 44.6% presented with
cavitary TB disease. We had no means of determining
the extent to which homeless persons experienced
diagnostic delays, but these data suggest that home-
less patients generally present with a more advanced
and infectious form of disease at the time of
diagnosis. A possible explanation may be the barriers
faced by homeless persons to medical care, as
reported in other studies.13,14 Lack of health insur-
ance is a problem for most homeless people in several
countries, including the United States.13 Although
Portugal has a universal health care system, the
homeless are likely to prioritise subsistence needs
such as food and shelter, which may delay their access
to health care services, as described in previous
studies.14 By fulfilling the basic needs of the homeless,
providing them with easy access to medical care and
facilitating anti-tuberculosis treatment for this group,
we can increase their chances of treatment success. As
mentioned above, there was a high prevalence of
alcohol and drug consumption among the homeless.
As persons with addictions are more likely to
procrastinate and refuse medical care,15 delays in
seeking medical care increase the risk of community
transmission, especially if homeless persons live in
overcrowded social residences with poorly ventilated
rooms.16 TB treatment guidelines recommend longer
treatment for patients with cavitary TB disease,17
which can be difficult to achieve in homeless people
without additional support.
It may seem surprising that, in our study, the
prevalence of INH and/or RMP resistance was not
statistically higher in homeless subjects, despite a
higher prevalence of previous history of TB. In
Portugal, directly observed treatment is mandatory,
and for homeless TB patients, there are partnerships
with organisations that help ensure that homeless
persons, drug users and HIV-co-infected patients
receive treatment.18 This is likely to improve treat-
ment adherence and thereby reduce the acquisition of
drug resistance. In our study, most negative outcomes
among homeless persons were death, rather than loss
to follow-up. Nevertheless, 9.4% of the homeless
were lost to follow-up and 4.7% were transferred
out, indicating that TB is still not effectively
controlled in this group.
Table 4 Multiple logistic regression to identify factors associated with unsuccessful treatment among homeless tuberculosis patients
Variables Coefficients SE P value OR (95%CI)
Intercept 2.920 0.371 ,0.001 —
Age 0.032 0.006 ,0.001 1.033 (1.021–1.045)
Injection drug use 0.721 0.256 0.002 2.056 (1.247–3.403)
HIV co-infection 0.759 0.249 0.005 2.135 (1.312–3.494)
TB¼ tuberculosis; SE¼ standard error; OR¼ odds ratio; CI¼ confidence interval; HIV¼ human immunodeficiency virus.
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Despite all efforts by governmental agencies and
non-governmental organisations worldwide, previ-
ous studies have also reported poorer outcomes
among homeless people.2,3,19 However, predictors
of unsuccessful treatment outcomes among the
homeless are not well documented in the literature.
Our study identified age, IDU and HIV co-infection
to be significantly associated with unsuccessful
treatment outcome. These factors are also known
predictors for poor outcomes in non-homeless per-
sons.20,21 The inverse relationship between age and
TB treatment success has been previously reported in
the literature and can be explained by general
physiological deterioration with age.20,22 It is also
well known that homeless persons die prematurely,
mainly due to infectious diseases.23 Previous studies
have also shown an association between IDU and
poor TB outcomes, mainly due to poor adherence.10
However, other study findings suggest that adherence
among drug users is improved when DOT is provided
with methadone or combined with monetary incen-
tives, which can be useful in this population.24
Several studies have also reported that HIV co-
infection is associated with higher mortality and
unsatisfactory outcomes among TB patients.11,25 It is
not known whether HIV patients in our study
received highly active antiretroviral therapy
(HAART), but it is known that patients who received
HAART during anti-tuberculosis treatment had
better outcomes and more rapid sputum conver-
sion.25 It is therefore particularly important to ensure
adherence to HAARTand anti-tuberculosis treatment
among the homeless to improve treatment outcome
and reduce the risk of TB transmission. The final
regression model exhibited an AUC estimated at
0.676, reflecting a relatively low discrimination
ability. Previous studies identified mental illness and
malnutrition as factors associated with unsuccessful
treatment outcomes; other factors may also be
implicated.26
We recognise the limitations in our study: first, TB
incidence among the homeless was only calculated for
2011 as this is the most recent year with official
statistics on the number of homeless people in
Portugal. Second, estimating TB incidence among
the homeless could be problematic, as the total
number of homeless persons may be underreported
and TB in this group may have been underdiagnosed.
To mitigate this limitation, we included reliable data
from the National Census and SVIG. However, an
ascertainment bias cannot be excluded, as the study is
based on notification data. Although TB notification
is mandatory in Portugal, there is no guarantee that
diagnostic capacity and proactive case-finding efforts
were similar in all regions. Finally, we only evaluated
TB disease and not LTBI, although LTBI control may
also reduce TB in homeless persons.
The major strengths of our study were its nation-
wide scope, the inclusion of all reported TB cases, the
analysis of multiple risk factors and adequate control
of confounding variables.
Further prospective studies are needed to determine
other predictors of unsuccessful treatment to optimise
TB control in this vulnerable population.
CONCLUSIONS
TB disease is highly prevalent among homeless
persons, and is higher in regions with greater TB
incidence in non-homeless patients. Homeless TB
patients had a higher prevalence of alcohol/drug use,
previous TB, HIV co-infection, smear positivity and
cavitary TB disease than non-homeless patients. The
rate of unsuccessful TB treatment outcomes is also
higher in this population, mainly due to higher
mortality. Age, IDU and HIV co-infection are
significantly associated with unsuccessful treatment
outcomes. To achieve the national goal of TB
elimination, we need to develop measures that
specifically target homeless persons.
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R E S U M E
CONT EX T E : La tuberculose (TB) est un souci majeur
dans les populations a` haut risque comme les personnes
sans domicile fixe.
OB J E C T I F S : Evaluer le taux d’incidence de la TB et les
re´sultats du traitement parmi des patients sans domicile
fixe au Portugal et identifier les facteurs de pre´diction
d’e´chec du traitement de la TB parmi ces patients.
S CH E´MA : Etude re´trospective de cohorte incluant tous
les patients TB notifie´s au Portugal entre 2008 et 2014.
Les caracte´ristiques des patients sans domicile fixe ont
e´te´ e´value´es et les facteurs de pre´diction d’e´chec du
traitement de la TB ont e´te´ de´termine´s par re´gression
logistique.
R E´ S U LTAT S : Le taux d’incidence de la TB parmi les
personnes sans domicile fixe a e´te´ de 122/100 000, et il a
e´te´ positivement corre´le´ avec l’incidence de la TB parmi
le reste de la population. Les patients tuberculeux sans
domicile fixe avaient une pre´valence plus e´leve´e de
consommation d’alcool et/ou de drogues, de co-
infection au virus de l’immunode´ficience humaine
(VIH), de forme caverneuse et de frottis positif. Le
taux d’e´chec du traitement a e´te´ de 28,6% ; l’e´chec a e´te´
significativement associe´ a` un aˆge plus avance´, a` la
consommation de drogues injectables et a` la co-infection
par le VIH.
C O N C L U S I O N : L’incidence de la TB parmi les
personnes sans domicile fixe a e´te´ cinq fois plus e´leve´e
que celle du reste de la population et plus haute dans les
re´gions ou` l’incidence dans le reste de la population est
e´galement plus e´leve´e. Leur taux d’e´chec du traitement a
e´te´ plus faible. Les facteurs de pre´diction d’e´chec du
traitement ont e´te´ l’aˆge, la consommation de drogues
injectables et la co-infection a` VIH. Des programmes de
TB inte´gre´s ciblant les patients sans domicile fixe et les
autres, avec des mesures spe´cifiques adapte´es a` leurs
caracte´ristiques particulie`res, pourrait contribuer a`
l’e´limination de la TB au Portugal.
R E S UM E N
MA R C O D E R E F E R E N C I A: La tuberculosis (TB)
constituye una gran preocupacio´n en las poblaciones
muy vulnerables como las personas sin hogar.
OB J E T I VO S: Evaluar la tasa de incidencia de TB y los
desenlaces terape´uticos en las personas sin domicilio en
Portugal y definir los factores prono´sticos de fracaso
terape´utico en este grupo de la poblacio´n.
M E´ TODO: Fue este un estudio retrospectivo de cohortes
de todos los pacientes con diagno´stico de TB notificados
del 2008 al 2014 en Portugal. Mediante un ana´lisis de
regresio´n logı´stica se analizaron las caracterı´sticas de los
pacientes tuberculosos sin hogar y los factores
prono´sticos de fracaso terape´utico.
R E S U LTADO S: La tasa de incidencia de TB en la
poblacio´n sin hogar fue 122 por 100 000 personas y
exhibio´ una correlacio´n positiva con la incidencia de TB
en las personas con domicilio. Los pacientes con
diagno´stico de TB y sin hogar presentaron una
prevalencia ma´s alta de consumo de alcohol y/o de
drogas, de coinfeccio´n por el virus de la
inmunodeficiencia humana (VIH), de lesiones
cavernosas y de resultados positivos de la baciloscopia.
La tasa de fracaso terape´utico en esta poblacio´n fue
28,6% y se asocio´ de manera significativa con una
mayor edad, el consumo de drogas intravenosas y la
coinfeccio´n por el VIH.
CONC LU S I O´ N: La incidencia de TB en las personas sin
hogar fue cinco veces mayor que en las personas con
domicilio y fue ma´s alta en las regiones con una mayor
incidencia de TB en las personas con domicilio. La tasa
de e´xito terape´utico en las personas sin hogar fue ma´s
baja. Los factores prono´sticos de fracaso terape´utico
fueron la edad, el consumo de drogas intravenosas y la
coinfeccio´n por el VIH. La ejecucio´n de programas
integrados de atencio´n de la TB dirigidos a las personas
sin hogar y con domicilio, que comporten medidas
especı´ficas que aborden sus caracterı´sticas particulares,
podrı´a contribuir a la eliminacio´n de la TB en Portugal.
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